Delivery Order SPE2DB22D2009-SPE2DB25FM0AG

Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL. The contract is a firm fixed-price delivery order with a ceiling value of $5,870.11 and a period of performance through April 16, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has a total ceiling value of $1,879.98 and an ultimate completion date of January 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract is a firm fixed-price delivery order with a ceiling value of $3,387.43 and a period of performance through April 16, 2025. The contract is not set aside and was awarded on April 15, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has a total ceiling value of $9,480.07 and runs through September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, with a total ceiling value of $38,652.85. The contract is a firm fixed price delivery order that runs through April 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has a ceiling value of $8,111.16 and an ultimate completion date of March 14, 2025. It is a firm fixed price contract and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has a ceiling value of $18,081.29 and a completion date of January 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The delivery order has a ceiling value of $3,484.36 and a period of performance through May 7, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract has a firm fixed price and is not set aside. The total ceiling value of the contract is $25,835.76, with a period of performance through June 13, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,093.70, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication to support military and government healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FM0AG
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The contract has a ceiling value of $23,623.90 and is a firm fixed-price delivery order with a performance period through July 3, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. This delivery order is likely part of the company's broader support to federal medical procurement needs, particularly for the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 10/1/25, 9:59 AM